discovered a new factor in the pathology of Parkinson's disease, which in the future may serve as a target for developing new ...

discovered a new factor in the pathology of Parkinson's disease, which in the future may serve as a target for developing new ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

Management of axial signs (postural instability, freezing) and cognitive decline in Parkinson's disease is unsatisfactory with the current medical treatment. Subthalamic nucleus stimulation is an ...

Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...

Parkinson’s Disease (PD) is a common brain disorder that affects movement and is most often linked with aging. It’s the second most common age-related brain disease, affecting millions worldwide.

this discovery may broaden the impact of such treatments beyond Parkinson’s Disease. These findings were published in the ...